Privia Health Group, Inc. (PRVA) Tops Q3 EPS by 15c, provides guidance

Privia Health Group, Inc. (NASDAQ: PRVA) reported Q3 EPS of $0.20, $0.15 better than the analyst estimate of $0.05. Revenue for the quarter came in at $437.9 million versus the consensus estimate of $414.17 million.

GUIDANCE:

Privia Health Group, Inc. sees FY2024 revenue of $1.675 billion, versus the consensus of $1.67 billion.

For earnings history and earnings-related data on Privia Health Group, Inc. (PRVA) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• SanDisk (SNDK) PT Raised to $3,000 at Bernstein SocGen Group, 'We believe this is not understood by the Street'